{"university":{"openalex_id":"I106165777","name":"University of Central Florida"},"topic":"lung-aging","total_matching":2,"offset":0,"next_offset":null,"records":[{"doi":"https://doi.org/10.1016/j.ebiom.2018.12.052","title":"Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study","source_url":"https://doi.org/10.1016/j.ebiom.2018.12.052","source_name":"EBioMedicine","cited_by_count":1261,"is_open_access":true,"openalex_work_id":"W2906721882","publication_date":"2019-01-04","publication_year":2019,"university_research_work_topics":[{"topic_slug":"lung-aging"}]},{"doi":"https://doi.org/10.1016/j.ebiom.2023.104481","title":"Senolytics dasatinib and quercetin in idiopathic pulmonary fibrosis: results of a phase I, single-blind, single-center, randomized, placebo-controlled pilot trial on feasibility and tolerability","source_url":"https://doi.org/10.1016/j.ebiom.2023.104481","source_name":"EBioMedicine","cited_by_count":287,"is_open_access":true,"openalex_work_id":"W4322490917","publication_date":"2023-02-27","publication_year":2023,"university_research_work_topics":[{"topic_slug":"lung-aging"}]}],"automation_disclosure":"Generated automatically from cited source metadata. No scientist, clinician, researcher, editor, or human reviewer evaluates this publication before release."}